624.80
+1.80
+(0.29%)
At close: March 3 at 2:36:58 PM CST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AFEYAN NOUBAR BOGHOS Director | Sale | Jul 31, 2024 | 6,856,160 |
| BANCEL STEPHANE J Chief Executive Officer | Stock Award(Grant) | Feb 12, 2025 | 21,109,100 |
| BERENSON STEPHEN A. Director | Conversion of Exercise of derivative security | May 3, 2024 | 22,203 |
| GARAY ARPA Officer | Sale | Dec 6, 2023 | 3,690 |
| HOGE STEPHEN President | Conversion of Exercise of derivative security | Feb 27, 2025 | 1,606,120 |
| HORNING SANDRA Director | Conversion of Exercise of derivative security | Apr 28, 2023 | 1,373 |
| KLINGER SHANNON THYME Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 24,735 |
| MOCK JAMES M Chief Financial Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 14,705 |
| NABEL ELIZABETH G Director | Conversion of Exercise of derivative security | May 3, 2024 | 2,105 |
Related Tickers
ATOS.MX Atossa Therapeutics, Inc.
14.70
-8.13%
INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
A89.MU Adocia SAS A
5.11
+9.30%
OCGN.MX Ocugen, Inc.
13.35
0.00%
NVV1.DU Novavax Inc
7.96
+16.74%
NVV1.F Novavax, Inc.
7.76
-3.46%
CRMD CorMedix Inc.
9.59
-7.43%
VERU Veru Inc.
0.5013
-3.54%
MRSN Mersana Therapeutics, Inc.
0.4800
-8.29%
ATOS Atossa Therapeutics, Inc.
0.7410
-3.23%